CXCR4 receptor as a promising target for oncolytic drugs

Y Lavrovsky, YA Ivanenkov, KV Balakin… - Mini Reviews in …, 2008 - benthamdirect.com
There has been considerable in vivo evidence that chemokine receptor CXCR4 and its
endogenous ligand CXCL12 modulate some important physiological and …

CXC chemokine receptor 4 (CXCR4) blockade in cancer treatment

S Bao, M Darvishi, AH Amin, MT Al-Haideri… - Journal of cancer …, 2023 - Springer
CXC chemokine receptor type 4 (CXCR4) is a member of the G protein-coupled receptors
(GPCRs) superfamily and is specific for CXC chemokine ligand 12 (CXCL12, also known as …

Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12

AK Singh, RK Arya, AK Trivedi, S Sanyal… - Cytokine & growth factor …, 2013 - Elsevier
Although chemokines are well established to function in immunity and endothelial cell
activation and proliferation, a rapidly growing literature suggests that CXC Chemokine …

The CXCL12-CXCR4 signaling axis plays a key role in cancer metastasis and is a potential target for developing novel therapeutics against metastatic cancer

P Yang, Y Hu, Q Zhou - Current Medicinal Chemistry, 2020 - ingentaconnect.com
Metastasis is the main cause of death in cancer patients; there is currently no effective
treatment for cancer metastasis. This is primarily due to our insufficient understanding of the …

Preclinical development of a novel class of CXCR4 antagonist impairing solid tumors growth and metastases

L Portella, R Vitale, S De Luca, C D'Alterio, C Ierano… - PloS one, 2013 - journals.plos.org
The CXCR4/CXCL12 axis plays a role in cancer metastases, stem cell mobilization and
chemosensitization. Proof of concept for efficient CXCR4 inhibition has been demonstrated …

The role of CXCR3 and its ligands in cancer

X Wang, Y Zhang, S Wang, H Ni, P Zhao… - Frontiers in …, 2022 - frontiersin.org
Chemokines are a class of small cytokines or signaling proteins that are secreted by cells.
Owing to their ability to induce directional chemotaxis of nearby responding cells, they are …

Drug design targeting the CXCR4/CXCR7/CXCL12 pathway

D Xu, R Li, J Wu, L Jiang… - Current topics in medicinal …, 2016 - benthamdirect.com
Under physiological conditions, CXCL12 modulates cell proliferation, survival,
angiogenesis, and migration mainly through CXCR4. Interestingly, the newly discovered …

Translating an antagonist of chemokine receptor CXCR4: from bench to bedside

D Wong, W Korz - Clinical Cancer Research, 2008 - AACR
The majority of current cancer therapies focus on a primary tumor approach. However, it is
metastases that cause the majority of cancer deaths. The metastatic process has been …

The Role of CXCL11 and its Receptors in Cancer: Prospective but Challenging Clinical Targets

J Wang, X Ouyang, W Zhu, Q Yi, J Zhong - Cancer Control, 2024 - journals.sagepub.com
Chemokine ligand 11 is a member of the CXC chemokine family and exerts its biological
function mainly through binding to CXCR3 and CXCR7. The CXCL11 gene is ubiquitously …

Development and Therapeutic Perspectives of CXCR4 Antagonists for Disease Therapy

J Yang, E Tian, L Chen, Z Liu, Y Ren, W Mao… - European Journal of …, 2024 - Elsevier
Abstract Chemokine receptor 4 (CXCR4) is a subtype receptor protein of the GPCR family
with a seven-transmembrane structure widely distributed in human tissues. CXCR4 is …